IOL

Investigators put forth a list of considerations for surgeons ahead of lens removal in pediatric patients

MELT-300 is a non IV, non-opioid tablet that combines fixed doses of midazolam (3mg) and ketamine (50mg).

The organization is providing free cataract resources for patients and professionals, including fact sheets, social media graphics, a dedicated web page and expert video.

The company is in the process of seeking regulatory approvals for the lens in the US and Europe.

The AIOLIS will be used to clinically evaluate patients’ perception of visual disturbances following premium IOL cataract surgery.

This research ultimately could enhance the manufacture of eye implants universally used in cataract and refractive surgeries.

Physicians should consider the roles of verbal and ocular anesthesia.

The angled bow-tie pattern of astigmatism was corrected more accurately compared with the asymmetric bow-tie pattern of astigmatism

A singular celebration of science over the decades

The A-IOL aims to correct both near and distance eyesight, reduce reliance on glasses or contact lenses, have no glare or halos, and restore the eye’s ability to focus.

Despite recognition of lenticular glutathione’s importance in lens formation for decades, why it declines with age remains a mystery.

BVI lenses feature a unique C-loop haptic design, known as “POD,” introduced to the market with the launch of the PODEYE hydrophobic IOL in Europe in 2012.

One year after implantation, the enduring IOP reduction remained consistent across all 3 dose strengths.

Alice Epitropoulos, MD, discusses the importance of considering ocular surface health in cataract surgery patients.

The company’s EVO family of Implantable Collamer Lenses for myopia, astigmatism and presbyopia, are designed to correct vision through a minimally invasive procedure.

The Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.

According to the company, the milestone underscores Vivity’s wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.

Seth Pantanelli, MD discusses the differences between traditional monofocal intraocular lenses (IOLs) and aspheric options.

The implantable lenses can offer an advantage over laser surgery.

Patients are encouraged to choose the optimal technology for their particular situation.

David Hutton of Ophthalmology Times talks with Eric Donnenfeld, MD about his presentation "Small Aperture IOL for Irregular Corneas" at this year's Hawaiian Eye and Retina 2024 Meeting.

Patient selection is important.

David Hutton of Ophthalmology Times talks with William Trattler, MD, about his presentation "Toric IOL pearls for Correcting Lower Levels of Astigmatism" at this year's Hawaiian Eye and Retina 2024 Meeting.

GreenMan app provides patients an opportunity to test drive various IOL options before cataract surgery via virtual and augmented reality.

A tailored treatment plan can help surgeons offer personalized care for patients.

Mariam Maghribi, Chief Business Officer for Shifamed, spoke with Ophthalmology Times about the Atia Vision IOL device at this year's American Academy of Ophthalmology meeting.

Daniel Chang, MD, spoke with Ophthalmology Times about his poster "Clinical performance of a diffractive, extended depth-of-focus IOL, with violet light filtering and high-resolution lathing" at this year's American Academy of Ophthalmology meeting.

Anthony Wallace, BS, MBA, vice president and general manager of the surgical business at Bausch + Lomb North America spoke with Ophthalmology Times about 3 new technologies the company launched at this year's American Academy of Ophthalmology meeting.

EVO ICLs, which evolved from early generation ICLs, offer a lens-based alternative for the correction/reduction of refractive error in people who currently use glasses and/or contact lenses for vision correction.

AffaMed Technologies is the joint venture between AffaMed Therapeutics and SIFI.